Fig. 3From: Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapyThe depiction of genomic organization of the human Claudin18 gene locus on chromosome 3q22, Claudin18.1 and CLaudin18.2 result from alternative splicing of the first exonBack to article page